Skip to content
Disclosery

13F-HR filed by ACUTA CAPITAL PARTNERS, LLC

ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 33 holding rows worth $153,941,445.

Accession
0001104659-24-061603
Filer
CIK 1582844
Filed
2024-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2024

A holdings report, 33 entries on the cover page, a total value of $153,941,445 stated on the cover page (in dollars after the unit check, H1), rows summing to $153,941,445 with VALUE read as dollars as filed, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
OCULAR THERAPEUTIX INC67576A100COM2,635,287$23,981,112dollars as filed
PRAXIS PRECISION MEDICINES I74006W207COM NEW162,302$9,903,668dollars as filed
Mersana Therapeutics Inc59045L106Common Stock2,164,628$9,697,533dollars as filed
TAYSHA GENE THERAPIES INC877619106COMMON STOCK3,333,333$9,566,666dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM326,787$8,803,642dollars as filed
SAREPTA THERAPEUTICS INC803607100COM64,162$8,306,413dollars as filed
VAXCYTE INC COM92243G108Stock104,830$7,160,937dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock396,099$6,967,381dollars as filed
Tourmaline Bio Inc89157D105Common Stock261,108$5,979,373dollars as filed
Applied Therapeutics Inc03828A101Common Stock792,000$5,385,600dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock184,500$5,237,955dollars as filed
DISC MEDICINE INC COM254604101Stock76,800$4,781,568dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock143,777$4,633,933dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW109,000$4,574,730dollars as filed
WHITEHAWK THERAPEUTICS INC00032Q104CMN1,849,402$4,327,601dollars as filed
HILLEVAX INC43157M102COM250,609$4,167,628dollars as filed
CRINETICS PHARMACEUTICALS INC COM22663K107Stock78,403$3,670,044dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM199,433$3,492,072dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock465,079$3,050,918dollars as filed
IMMUNOVANT INC45258J102COM92,346$2,983,699dollars as filed
VERASTEM INC92337C203COMMON STOCK207,095$2,443,721dollars as filed
ARCELLX INC COMMON STOCK03940C100Stock34,500$2,399,475dollars as filed
KURA ONCOLOGY INC COM50127T109Stock90,000$1,919,700dollars as filed
INSMED INC COM PAR $.01457669307Stock61,718$1,674,409dollars as filed
AGIOS PHARMACEUTICALS INC00847X104COM55,262$1,615,861dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM103,992$1,429,890dollars as filed
MEREO BIOPHARMA GROUP PLC589492107CMN397,884$1,313,017dollars as filed
LYRA THERAPEUTICS INC55234L105COM173,320$1,078,050dollars as filed
CYPHERPUNK TECHNOLOGIES INC52187K200COM NEW354,166$942,082dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM20,000$933,800dollars as filed
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK13,300$920,360dollars as filed
CELLECTAR BIOSCIENCES INC15117F807COM143,500$571,130dollars as filed
NUVATION BIO INC67080N119WARR90,832$27,477dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-24-061603this filing2024-05-15acceptance time not in the bulk data set